Table 1. DMVhi cohort age-group and gender-specific prevalence rates of undiagnosed type 2 diabetes, impaired glucose tolerance and impaired fasting glucose (n = 29,144; male = 12,929 (44%); female = 16,215 (56%)).
| Rates of T2D, IFG and IGT in the DMVhi Cohort | ||||||
|---|---|---|---|---|---|---|
| n | T2D | IFG | IGT | Normal | ||
| All ages | 29144 | 1.8% | 7.1% | 2.9% | 88.1% | |
| Male | 12929 | 2.9% | 10.0% | 4.2% | 83.0% | |
| Female | 16215 | 1.0% | 4.9% | 1.9% | 92.2% | |
| 45–54 | 9387 | 0.8% | 4.8% | 1.3% | 93.0% | |
| Male | 4016 | 1.3% | 7.2% | 2.1% | 89.4% | |
| Female | 5371 | 0.5% | 3.1% | 0.7% | 95.7% | |
| 55–64 | 11259 | 1.9% | 7.1% | 3.1% | 87.1% | |
| Male | 4917 | 3.0% | 11.1% | 4.4% | 81.5% | |
| Female | 6342 | 1.0% | 5.5% | 2.1% | 91.4% | |
| 65–75 | All | 8498 | 2.9% | 2.5% | 4.4% | 84.0% |
| Male | 3996 | 4.4% | 11.4% | 5.9% | 78.3% | |
| Female | 4502 | 1.7% | 6.1% | 3.1% | 89.1% | |
T2D = type 2 diabetes, IGT = impaired glucose tolerance and IFG = impaired fasting glucose. Gender differences for DMVhi cohort and for each age group: p<0.001